Trimethylamine-N-oxide (TMAO) impairs β-oxidation in cardiac mitochondria. TMAO decreases pyruvate metabolism via impaired substrate flux. Increased TMAO content induces energy metabolism disturbances in the heart. Increased TMAO concentration is a risk factor for heart failure progression.